Article Information
History
- October 6, 2020.
Article Versions
- Version 1 (February 15, 2020 - 13:36).
- Version 2 (April 13, 2020 - 23:24).
- You are currently viewing Version 3 of this article (October 6, 2020 - 20:53).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Shinobu Hirai1,†,*,
- Hideki Miwa1,2,
- Tomoko Tanaka1,
- Kazuya Toriumi3,
- Yasuto Kunii4,
- Takuya Sakamoto5,
- Mizuki Hino4,
- Ryuta Izumi4,
- Atsuko Nagaoka4,
- Hirooki Yabe4,
- Tomoya Nakamachi6,
- Seiji Shioda7,
- Takashi Dan8,
- Toshio Miyata8,
- Yasumasa Nishito9,
- Hiroko Shimbo1,
- Kazuhiro Suzuki3,
- Mitsuhiro Miyashita3,
- Masanari Itokawa3,
- Makoto Arai3 and
- Haruo Okado1,†,*
- 1Neural Development Project, Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan
- 2Molecular Neuropsychopharmacology Section, Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo 187-8553, Japan
- 3Schizophrenia Research Project, Department of Psychiatry and Behavioral Sciences, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan
- 4Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima 960-1295, Japan
- 5Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda, Chiba 278-8510, Japan
- 6Laboratory of Regulatory Biology, Graduate School of Science and, Engineering, University of Toyama, Toyama 930-8555, Japan
- 7Global Research Center for Innovative Life Science, Peptide Drug Innovation, Hoshi University, Tokyo 142-8501, Japan
- 8Division of Molecular Medicine and Therapy, Tohoku University Graduate School of Medicine, Miyagi 980-8575, Japan
- 9Center for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan
- ↵*Correspondence should be addressed to Shinobu Hirai and Haruo Okado, Neural Development Project, Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo 156-8506, Japan., E-mail: hirai-sn{at}igakuken.or.jp (S.H.) and okado-hr{at}igakuken.or.jp (H.O.)
↵† These authors contributed equally to this work.